IMUX Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IMUX shares is 74, representing 64.94% of the company's common stock.

ACADIAN ASSET MANAGEMENT LLC, in the last quarter, reduced its stake in IMUX by -57.1% restricting it's holding to 239.96 thousand shares of worth nearly $316.00K. UBS OCONNOR LLC also lessened -72.06% of the IMUX shares from its portfolio, reducing its holding to 167.69 thousand shares of worth $221.34K. SUSQUEHANNA INTERNATIONAL GROUP, LLP also shunned IMUX shares holding by -60.46% last quarter which brought its holding to 132.45 thousand shares worth $174.83K.

As per its latest 13F filing, GEODE CAPITAL MANAGEMENT, LLC increased its stake in IMUX by 114.47% in the last quarter. The institutional holder raised its holding to 895.65 thousand shares having worth more than $1.18M. RENAISSANCE TECHNOLOGIES LLC also added 898.95% more shares of IMUX to its portfolio, raising its holding to 747.27 thousand shares of worth $986.00K. 683 CAPITAL MANAGEMENT, LLC also increased its IMUX shares holding by 100% which brought its holding to 699.3 thousand shares worth $923.08K.

The insider with the most stakes in IMUX is Vitt Daniel , President and CEO at the company. Additionally, IMUX stock is highly held by Chief Medical Officer Muehler Andreas and Chief Operating Officer Groeppel Manfred among others.

Company executives, directors, and other insiders own 1.04% percent of Immunic, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which IMUX insiders have sold stock, totaling 0 shares. Insiders that have sold shares include VITT DANIEL, GROEPPEL MANFRED, and NASH DUANE.

There have been 1 transaction(s) during the past 6-months in which Immunic, Inc. insiders have bought stock, totalling 87300 shares

Around 87.3K Immunic, Inc. shares are held by insiders, which represents about 1.04% of IMUX stock.

IMUX President and CEO, Vitt Daniel holds the largest portfolio of the company's shares. IMUX shares owned by Vitt total nearly 390.88 thousand.

AMERICAN CENTURY COMPANIES INC is the largest institutional owner in IMUX which holds 20.94 thousand shares worth $27.64K or 0.05% of the total IMUX shares outstanding followed by GEODE CAPITAL MANAGEMENT, LLC with ownership of 895.65 thousand shares representing 2.02% of the IMUX ownership. RENAISSANCE TECHNOLOGIES LLC is the third largest stakeholder with 747.27 thousand shares or 1.69% of the ownership worth more than $986.00K.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IMUX is concerned, it is a stock which is optionable.

Number of IMUX shares short is 5.64M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 90.08M shares of IMUX are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IMUX has 52.16M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IMUX is 6.56.